GlassScriptPhysician profile
Kristie D Hayes
NPI 1902855257
$517.42
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2022: $14.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.02 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $65.89 | 2019 | |
| Celgene Corporation | $63.30 | 2019 | |
| Lilly USA, LLC | $42.43 | 2019 | |
| Mayne Pharma Commercial LLC | $40.10 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.52 | 2019 | |
| Amgen INC. | $24.29 | 2019 | |
| Galderma Laboratories, L.P. | $23.69 | 2019 | |
| Dermira, INC. | $23.00 | 2019 | |
| Pfizer INC. | $21.12 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.33 | 2022 | |
| Sun Pharmaceutical Industries INC. | $13.13 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.60 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristie Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.